Patients for Affordable Drugs in a recent report, “The Truth About Insulin Prices,” looks at how insulin prices surged, and the impact on patients.
According to the report, the global insulin market is dominated by three pharma giants: Eli Lilly, Novo Nordisk and Sanofi.
“Millions of Americans living with diabetes are forced to make hard decisions such as purchasing their medications or paying for other necessities like food and rent,” the report states. “Since type 1 patients require insulin to survive, many have resorted to rationing insulin or traveling to other countries to purchase the drug.”
To read the full report in PDF format, click here.